Skip to main content
Advertisement

Wellbrooke of Carmel: Wrong Parkinson's Dose - IN

Healthcare Facility:

The medication mix-up at Wellbrooke of Carmel involved Rytary, an extended-release drug used to treat Parkinson's symptoms. Federal inspectors found the facility failed to ensure proper pharmaceutical services for the resident, identified as Resident B in the October 3 complaint inspection.

Wellbrooke of Carmel facility inspection

The confusion began August 11 when a physician ordered four capsules of Rytary four times daily. The next day, nursing staff correctly updated the order to reflect the same dosage. But on August 30, the order was changed back to just one capsule four times daily.

Advertisement

Resident B moved to the facility's assisted living section September 11, and the reduced one-capsule dose continued. It wasn't until September 17 that the order was corrected to two capsules four times daily as the physician began titrating the resident back to the proper therapeutic level.

The Director of Nursing told inspectors the admitting nurse had initially entered the wrong dosage of one capsule, then quickly corrected it to four capsules. But when pharmacy staff reviewed the medication on August 30, they consulted an older patient profile and changed the order back to the incorrect single-capsule dose.

"The resident was supposed to receive four capsules instead of 1 capsule," the Director of Nursing explained during the October 2 interview. A weekend nurse had questioned the dosage, prompting the pharmacy review that led to the error.

The facility's Executive Director sent an email September 22 describing how the weekend supervisor had contacted the pharmacist August 30 to verify orders. The pharmacist recommended reducing the dose from four capsules to one, apparently after reviewing outdated patient information.

"The facility indicated the pharmacy may have looked at an older profile for Resident B," the Executive Director wrote.

A weekend nurse eventually caught the error. The physician then ordered two capsules four times daily to gradually restore the resident to the correct therapeutic dose.

Clinical Support Nurse 1 told inspectors October 3 that when the facility requests an immediate pharmacy review, "they expected the pharmacy would had reviewed the medications and gave recommendations accurately."

Resident B's medical record showed diagnoses including Parkinson's disease, history of stroke, and weakness. The resident required the higher Rytary dose to manage Parkinson's symptoms effectively.

Rytary contains a combination of carbidopa and levodopa, medications that help replace dopamine in the brain. Parkinson's patients depend on precise dosing to control tremors, stiffness, and movement problems. Underdosing can leave patients with inadequate symptom control.

The facility's November 2018 policy on consultant pharmacist reports states that pharmacy services will provide an Immediate Medication Regimen Review upon request. The policy indicates facilities may request licensed pharmacists perform these reviews to ensure medication safety.

The error persisted from August 30 through September 17 — more than two weeks during which Resident B received only one-fourth of the prescribed Rytary dose. The underdosing occurred while the resident was transitioning between care levels within the facility.

Federal inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents. The citation falls under regulations requiring facilities to provide pharmaceutical services meeting each resident's needs and employ or obtain services from licensed pharmacists.

The inspection was conducted in response to a complaint. Inspectors reviewed clinical records and interviewed nursing staff to document the medication error and the facility's response.

Wellbrooke of Carmel must submit a plan of correction addressing how it will prevent similar pharmaceutical errors. The facility needs to ensure nursing staff enter medication orders accurately and that pharmacy reviews use current patient profiles rather than outdated information.

The case highlights the critical coordination required between nursing staff and pharmacy services in long-term care settings. When multiple parties handle medication orders, clear communication and accurate record-keeping become essential to resident safety.

For Resident B, the physician's intervention to gradually restore the correct Rytary dose meant additional weeks of suboptimal Parkinson's symptom management while titrating back to therapeutic levels.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Wellbrooke of Carmel from 2025-10-03 including all violations, facility responses, and corrective action plans.

Additional Resources

🏥 Editorial Standards & Professional Oversight

Data Source: This report is based on official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial Process: Content generated using AI (Claude) to synthesize complex regulatory data, then reviewed and verified for accuracy by our editorial team.

Professional Review: All content undergoes standards and compliance oversight by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal, using professional regulatory data auditing protocols.

Medical Perspective: As emergency medical professionals, we understand how nursing home violations can escalate to health emergencies requiring ambulance transport. This analysis contextualizes regulatory findings within real-world patient safety implications.

Last verified: May 6, 2026 | Learn more about our methodology

📋 Quick Answer

WELLBROOKE OF CARMEL in CARMEL, IN was cited for violations during a health inspection on October 3, 2025.

The medication mix-up at Wellbrooke of Carmel involved Rytary, an extended-release drug used to treat Parkinson's symptoms.

What this means: Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at WELLBROOKE OF CARMEL?
The medication mix-up at Wellbrooke of Carmel involved Rytary, an extended-release drug used to treat Parkinson's symptoms.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in CARMEL, IN, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from WELLBROOKE OF CARMEL or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 155833.
Has this facility had violations before?
To check WELLBROOKE OF CARMEL's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.